|
Comparison of different phase II studies using sequential combinations of targeted agents for treating chronic lymphocytic leukemia. |
|
|
Honoraria - Abbvie; Janssen; Roche |
Consulting or Advisory Role - Abbvie; Janssen; Roche |
Research Funding - Janssen; Roche |
Travel, Accommodations, Expenses - Abbvie; Celgene; Janssen; Roche |
|
|
Honoraria - Abbvie; AstraZeneca; Janssen |
Consulting or Advisory Role - Abbvie; AstraZeneca; Janssen; Roche |
Speakers' Bureau - Abbvie; Janssen |
Research Funding - Abbvie; Acerta Pharma; Gilead Sciences; Janssen; Novartis; Roche |
Travel, Accommodations, Expenses - Abbvie; Janssen; Roche |
|
|
|
Travel, Accommodations, Expenses - Roche |
|
|
No Relationships to Disclose |
|
|
Honoraria - Abbvie; Gilead Sciences; Roche |
Consulting or Advisory Role - Abbvie; Gilead Sciences |
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Janssen; Roche |
|
|
|
Research Funding - Abbvie (Inst); Janssen; Roche (Inst) |
Travel, Accommodations, Expenses - Janssen; Mundipharma; Roche |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Roche |
|
|
Travel, Accommodations, Expenses - Abbvie |
|
|
Travel, Accommodations, Expenses - Roche |
|
|
Honoraria - Abbvie; Janssen; Mundipharma; Roche |
Consulting or Advisory Role - Abbvie; Janssen; Mundipharma; Roche |
Speakers' Bureau - Abbvie; Janssen; Mundipharma; Roche |
Research Funding - Abbvie; Janssen; Mundipharma; Roche |
Expert Testimony - Abbvie; Janssen; Mundipharma; Roche |
Travel, Accommodations, Expenses - Abbvie; Janssen; Mundipharma; Roche |
|
|
No Relationships to Disclose |
|
|
Honoraria - Abbvie; Becton Dickinson; Novartis; Roche |
Consulting or Advisory Role - Abbvie; Roche |
Research Funding - Abbvie; Celgene; Genentech; Janssen; Roche |
|
|
Honoraria - Abbvie; Genentech; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Pharmacyclics; Roche |
Consulting or Advisory Role - Abbvie; Genentech; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Pharmacyclics; Roche |
Speakers' Bureau - Abbvie; Genentech; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Pharmacyclics; Roche |
Research Funding - Abbvie; Gilead Sciences; Roche |
Travel, Accommodations, Expenses - Abbvie; Genentech; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Pharmacyclics; Roche |
|
|
Honoraria - Abbvie; Amgen; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Novartis; Roche |
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Novartis; Roche |
Research Funding - Abbvie; Amgen; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Novartis; Roche |
Travel, Accommodations, Expenses - Abbvie; Amgen; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Novartis; Roche |
|
|
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen-Cilag; Novartis; Roche |
Speakers' Bureau - Abbvie; Celgene; Gilead Sciences; Janssen-Cilag; Roche/Genentech |
Research Funding - Abbvie; Gilead Sciences; Janssen; Roche |
Travel, Accommodations, Expenses - GlaxoSmithKline; Mundipharma; Roche |
|
|
Honoraria - Abbvie; Gilead Sciences; Janssen; Roche |
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen; Roche |
Speakers' Bureau - Abbvie; Gilead Sciences; Janssen; Roche |
Research Funding - Abbvie; Gilead Sciences; Janssen; Roche |
Travel, Accommodations, Expenses - Janssen; Roche |